Welcome to the IDT family!

Your product is now available from Integrated DNA Technologies.

Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.

xGen NGS—made for you.

Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.

Welcome to the IDT family!

Find Archer now at IDT!

All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.

Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.

Explore how our NEW cGMP gRNA manufacturing service can accelerate your CRISPR therapeutics project

More posts in DECODED

  • Calculations: Converting from nanograms to copy number
  • What is CRISPR screening?
  • Comprehensive genomic profiling—what, why, and its future
  • Oligo synthesis: Why IDT is a leader in the oligo industry
  • Double-quenched probes increase signal to noise ratios by decreasing background fluorescence
  • Unraveling RNA—The importance of a 2' hydroxyl
  • What you need to know about gene fusions
  • What is a phosphodiester bond?
  • Troubleshooting your site-directed mutagenesis by PCR
  • Genome editing tip: A CRISPR RNA annealing step can increase editing efficiency
  • Amplicons and amplicon sequencing
  • Cloning strategies: Blunt-end cloning
  • Mechanical vs. enzymatic fragmentation approaches: Which method best improves library quality?
  • Consider ribonucleoprotein (RNP) instead of CRISPR plasmids!
  • Beginner’s guide to next generation sequencing
  • CRISPR-Cas nucleases: Understanding PAM requirements and Cas diversification strategies
  • Understanding the importance of 3’ UTR mutations in cancer research
  • How DNA ligation works
  • Luciferase, an alternative to fluorescence
  • How to use CRISPR-Cas9 technology to generate mice models for research
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Discover what's possible
800 328 2661
Contact Us
Applications
Cancer ResearchInfectious Disease ResearchRare & Inherited Genetic Disease ResearchAntibody Discovery
Protein Engineering
Support & Education
User guides & protocolsSafety data sheetsFrequently asked questionsSupplier informationHow to order and request a quoteVulnerability disclosure processContact us
Company
AboutLeadershipSustainabilityCareersNewsEvents
Products & Services
Oligos & ReagentsPCR / qPCR / dPCRCRISPR Gene EditingGene Synthesis & FragmentsNext Generation SequencingGene RegulationGMP Oligo ManufacturingCGMP CRISPR ManufacturingOEM & Additional ServicesProduct Savings
Tools
OligoAnalyzer ToolDNA Oligo EntryPrimerQuest ToolPredesigned qPCR AssaysPredesigned CRISPR-Cas9 gRNACRISPR HDR Design ToolgBlocks Gene Fragments EntryCodon Optimization ToolAll tools
Follow us
Instagram
Facebook
X
Linkedin
Youtube
Preferences
Language: ENG
Online Terms and Conditions of Sale
Privacy PolicyCookie PolicyPayment Information
Do Not Sell or Share My Data
Biosecurity Attestation
© 2025 Integrated DNA Technologies, Inc.
Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners, and may be registered in the USA and/or other jurisdictions. For specific trademark information, see www.idtdna.com/trademarks. For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.